Education
Questions and Answers About the Breast Cancer Prevention Trial (Part 2)
Published in Women's Health Weekly, February 15th, 1995
Will every woman in the trial receive tamoxifen'
The 16,000 women who will participate in the BCPT will be randomized (selected by chance) to receive either tamoxifen or a placebo (an inactive pill that looks like tamoxifen). In a process known as 'double blinding,' neither the participant nor her physician will know which pill she is receiving. Setting up a trial in this way allows researchers to clearly see what the true benefits and side effects of tamoxifen may be without the influence of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer (Diagnostics)
Relationship of Endogenous Estrogens and Breast Cancer in Postmenopausal Women - Breast Cancer (Diagnostics)
Technology Acquired for Detecting Estrogen-Dependent Cancer - Epidemiology (AIDS/HIV)
Young Women Now at Leading Edge of AIDS Epidemic - Epidemiology (Cancer)
NCI Reports Increased Cancer Incidence since Mid-1970s - Knowledge, Attitudes and Behavior
Lack of Knowledge May Explain Low Incidence of Breast-Feeding Moms - Nutrition
Magnesium Linked to Lower Incidence of Cerebral Palsy - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
